HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alessandro Broccoli Selected Research

Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)

11/2023Prolonged Complete Response with Lenalidomide in a Relapsed Diffuse Large B-Cell Lymphoma, Leg-Type: A Case Report.
9/2023Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets.
12/2022Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy.
1/2020Elderly Non-GCB Diffuse Large B-Cell Lymphoma Patient Responding to Lenalidomide after Epicardial Relapse: A Case Report.
1/2019Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice.
1/2016Prolonged disease-free survival in elderly relapsed diffuse large B-cell lymphoma patients treated with lenalidomide plus rituximab.
12/2011Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial.
3/2011Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma.
12/2010Immunophenotype and intermediate-high international prognostic index score are prognostic factors for therapy in diffuse large B-cell lymphoma patients.
8/2010Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alessandro Broccoli Research Topics

Disease

18Lymphoma (Lymphomas)
01/2023 - 11/2007
16Hodgkin Disease (Hodgkin's Disease)
04/2023 - 01/2012
12Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2023 - 10/2009
8Hairy Cell Leukemia
04/2024 - 10/2010
7Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2020 - 08/2010
6Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022 - 11/2013
6B-Cell Lymphoma (Lymphoma, B Cell)
09/2021 - 10/2009
4Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2024 - 08/2011
3Neoplasms (Cancer)
01/2020 - 12/2017
3Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2020 - 11/2007
3T-Cell Lymphoma (Lymphoma, T Cell)
01/2019 - 08/2014
3Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
11/2017 - 08/2013
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2021 - 12/2021
2Hematologic Neoplasms (Hematological Malignancy)
11/2020 - 01/2016
2Exanthema (Rash)
11/2020 - 10/2015
2Thrombocytopenia (Thrombopenia)
05/2018 - 06/2013
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
05/2018 - 01/2018
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
02/2018 - 11/2016
2Disease Progression
07/2015 - 06/2015
1Urinary Bladder Diseases (Bladder Diseases)
04/2024
1Second Primary Neoplasms (Neoplasms, Second)
04/2024
1Burkitt Lymphoma (Burkitt's Lymphoma)
02/2024
1Residual Neoplasm
01/2021
1Kidney Neoplasms (Kidney Cancer)
01/2020
1Atrial Fibrillation
01/2020
1Chronic Kidney Failure (Chronic Renal Failure)
01/2020
1Enteropathy-Associated T-Cell Lymphoma
01/2019
1Plasmablastic Lymphoma
06/2018
1Multiple Myeloma
06/2018
1Diarrhea
05/2018
1Infections
05/2018
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
12/2017
1Leukemia
11/2016
1Paraneoplastic Syndromes (Paraneoplastic Syndrome)
11/2016
1Vasculitis (Vasculitides)
11/2016
1Erythema elevatum diutinum
11/2016

Drug/Important Bio-Agent (IBA)

17Rituximab (Mabthera)FDA Link
02/2024 - 10/2009
11Brentuximab VedotinIBA
04/2023 - 08/2013
9Lenalidomide (CC 5013)FDA Link
11/2023 - 08/2011
6CladribineFDA LinkGeneric
04/2024 - 11/2016
6ibrutinibIBA
12/2021 - 03/2017
6Doxorubicin (Adriamycin)FDA LinkGeneric
10/2016 - 10/2009
6Mitoxantrone (Novantrone)FDA LinkGeneric
06/2016 - 07/2012
5fludarabineIBA
06/2016 - 11/2013
5Vincristine (Oncovin)FDA LinkGeneric
08/2014 - 10/2009
5Prednisone (Sone)FDA LinkGeneric
08/2014 - 10/2009
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2014 - 10/2009
4Bendamustine HydrochlorideFDA Link
12/2022 - 12/2013
4Bleomycin (Blenoxane)FDA LinkGeneric
10/2016 - 10/2009
3Methotrexate (Mexate)FDA LinkGeneric
09/2023 - 10/2009
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2023 - 04/2009
3idelalisibIBA
01/2022 - 03/2017
3ibritumomab tiuxetan (Zevalin)FDA Link
01/2020 - 08/2010
3Biosimilar PharmaceuticalsIBA
02/2018 - 01/2016
3Bortezomib (Velcade)FDA Link
01/2018 - 12/2013
2purineIBA
04/2024 - 10/2015
2Tyrosine Kinase InhibitorsIBA
11/2020 - 06/2013
2AnthracyclinesIBA
01/2020 - 01/2018
2Dacarbazine (DIC)FDA LinkGeneric
10/2016 - 04/2016
2Vinblastine (Vinblastine Sulfate)FDA Link
10/2016 - 04/2016
2VemurafenibIBA
10/2015 - 06/2015
2Anti-Bacterial Agents (Antibiotics)IBA
09/2015 - 01/2015
2Etoposide (VP 16)FDA LinkGeneric
07/2012 - 10/2009
1Histones (Histone)IBA
01/2024
1MethyltransferasesIBA
01/2024
1Lysine (L-Lysine)FDA Link
01/2024
1polatuzumab vedotinIBA
12/2022
1cyclopropapyrroloindoleIBA
12/2020
1Immune Checkpoint InhibitorsIBA
12/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1alovudineIBA
07/2019
1AntibodiesIBA
01/2019
1Cytostatic AgentsIBA
06/2018
1Thalidomide (Thalomid)FDA Link
06/2018
1Dexamethasone (Maxidex)FDA LinkGeneric
06/2018
1temsirolimusFDA Link
01/2018
1Filgrastim (Neupogen)FDA Link
12/2017
1venetoclaxIBA
03/2017
1ublituximabIBA
03/2017
1copanlisibIBA
03/2017
1obinutuzumabIBA
03/2017
110-propargyl-10-deazaaminopterinFDA Link
01/2017
1belinostatIBA
01/2017
1romidepsin (FK228)FDA Link
01/2017
1Biomarkers (Surrogate Marker)IBA
10/2016
1IfosfamideFDA LinkGeneric
04/2016

Therapy/Procedure

22Therapeutics
04/2024 - 11/2007
11Stem Cell Transplantation
01/2024 - 12/2013
10Drug Therapy (Chemotherapy)
09/2021 - 03/2011
4Autologous Transplantation
02/2024 - 04/2016
4Radiotherapy
12/2015 - 11/2007
3Aftercare (After-Treatment)
04/2024 - 10/2015
3Salvage Therapy
11/2023 - 12/2013
3Immunotherapy
10/2020 - 01/2018
3Radioimmunotherapy
06/2016 - 08/2010
2Homologous Transplantation
01/2024 - 01/2020
2Transplantation
01/2024 - 01/2019
2Combination Drug Therapy (Combination Chemotherapy)
09/2023 - 01/2020
1Bridge Therapy
01/2024
1Hematopoietic Stem Cell Transplantation
12/2020